Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 15, 2025
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 09, 2024
Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: a case report series.
Journal: Frontiers in immunology
Published: December 21, 2023
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: December 19, 2022
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.
Journal: Human vaccines & immunotherapeutics
Published: January 17, 2019
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Journal: Human vaccines & immunotherapeutics
Published: November 15, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026